Two Buy Ratings, Two Different Bets: Almonty's Q3 Headline Profit Meets a Split Analyst Crowd
Published on 11/16/2026 at 06:51 | Editorial boerse-global.deAlmonty shares climbed 8.5% on Friday, but the two research notes landing the same day told a more nuanced story than the single "buy" label suggests. Stifel cut its price target to US$18 from US$21 while keeping its buy rating, according to media reports. Alliance Global stood pat — reaffirming both its buy call and a US$26.25 target, and describing the recent weakness in the stock as a buying opportunity. Same verdict, markedly different levels of conviction.
The gap between those two numbers frames the real question for investors: how solid is the confidence when higher tungsten prices are driving the business, yet the reported profit leans heavily on valuation effects?
Revenue Is Real; the Bottom Line Is Another Matter
The third quarter of 2026 provides the backdrop. Almonty attributed its sharp top-line growth to higher tungsten prices, with revenue up 382% year on year to C$41.89 million. That is genuine business expansion rather than a shift in balance-sheet values.
Should investors sell immediately? Or is it worth buying Almonty?
Profit requires a closer read. The company posted a net profit of C$50.23 million, a figure that included C$47.9 million in non-cash gains. Adjusted operating earnings before interest, taxes, depreciation and amortization came in at C$14.6 million. A large surplus, in other words, is not automatically proof of equivalent operating strength — a distinction that matters more than the shared "buy" tag on the two analyst notes.
Sangdong Back in Production After Three Decades
On the operational side, Almonty said Sangdong produced tungsten concentrate in September for the first time since 1993. More than 90% of Phase I output is contractually committed, according to the company — a useful signal for the sales side, though distinct from revenue already booked or profit actually realized.
A Courtroom Thread Runs Alongside the Growth Story
Legal matters added a separate layer. Deutsche Rohstoff disclosed on Wednesday that it had filed suit against Almonty in Canada, asserting claims totaling roughly US$67 million. Those include rights to 3.5 million shares from a conversion as well as repayment of debt. Deutsche Rohstoff also said Almonty had filed its own action against it, and that the two proceedings have been consolidated. The claims represent the parties' respective assertions.
Weighing it all together, Almonty cannot be reduced to either the share-price jump or the buy ratings. Higher tungsten prices, operating results and contracted production need to line up. The divergent price targets lay bare how much room for interpretation remains in that valuation — and what counts is not the volume of confidence, but its economic footing.
Ad
Almonty Stock: New Analysis - 16 November
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
